Two Eye-Catching Stocks: Guess’, Inc. (NYSE:GES), AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG)


Guess’, Inc. (NYSE:GES)

Guess’, Inc. (NYSE:GES) represented a move of 5.31 percent or $-0.96 per share and closed its previous day trading session at $15.87. 1.04 Million Shares were traded in the last trading session with an Average Volume of 1.49 Million Shares. The stock currently has a Market Capitalization of 1.29 Billion.

Guess, Inc. was founded to create an iconic global lifestyle brand with strongly held values. They design, market, distribute and license one of the world’s leading lifestyle collections of contemporary apparel and accessories for men, women and children that reflect the American lifestyle and European fashion sensibilities. Their apparel is marketed under numerous trademarks including GUESS, GUESS?, GUESS U.S .A ., GUESS Jeans, GUESS? and Triangle Design, MARCIANO, Question Mark and Triangle Design, a stylized G and a stylized M, GUESS Kids, Baby GUESS, YES, Gc, G by GUESS and GUESS by MARCIANO (Guess Americas only). The lines include full collections of clothing, including jeans, pants, skirts, dresses, shorts, blouses, shirts, jackets, knitwear, intimate apparel, kids and infant’s apparel. They also distribute a broad range of products that complement their apparel lines, including eyewear, watches, handbags, footwear, outerwear, swimwear, fragrance, jewelry and other fashion accessories.

The stock traded between $ 9.56 and $19.62 over 1-Year time period showing its price to sales ratio of 0.57. Guess’, Inc. (NYSE:GES) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.

Right now, the stock has a 50-Day Simple Moving Average of $-6.22 and 200-Day Simple Moving Average of $7.84. Its Price to Free Cash Flow is 0 and Price to Book of 1.41.

Analyst’s recommended the stock as 2.8 where 1 represents Strong Buy and 5 represents Sell.

In the last Quarter, Guess’, Inc. (NYSE:GES) reported its Actual EPS of $0.12/share. The analysts offering Earnings Estimates for the company were believing that Guess’, Inc. could bring EPS of $0.12/share. The difference between Actual EPS and Estimated EPS was 0 Percent. Thus showing an Earnings Surprise of 0 Percent.

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG)

In the last trading session, AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) added its value by 1.46% closing at the price of $13.9. The stock currently has market capitalization of 490.82 Million, with average volume of 839.63 Million shares.

Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) is showing beta of 0.94. This particular value of beta suggests that AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) has historically moved 94% for every 100% move in the benchmark, based on price level.

EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) is at $-6.08.

The stock currently has RSI of 50.69. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company that utilizes its proprietary nanoparticle technology for the development and commercialization of therapeutic iron compounds to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease. Ferumoxytol, the company’s key product candidate, is being developed for use as an intravenous iron replacement therapeutic for the treatment of iron deficiency anemia in chronic kidney disease patients.Combidex(r), the company’s other product under development, is an investigational functional molecular imaging agent consisting of iron oxide nanoparticles for use in conjunction with magnetic resonance imaging to aid in the differentiation of cancerous from normal lymph nodes. In March 2005, the company received an approvable letter from the FDA with respect to Combidex, subject to certain conditions.

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) topped its 52-week high price of $25.20 on 03/08/17 and 52-Week Low Price of $11.93 on 11/02/17. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 7.40% and monthly volatility of 6.14% respectively.